PartnerFacts
Data last updated: Oct 23, 2026, 5:45 PM ETLatest filing: Oct 22, 2026Now: Oct 24, 2026, 5:12 AM ET

Sponsor Check › Person

PM
No photo found yet (own website and image search run after this page is viewed)

Patrick T. Mooney

Named as an officer, director or promoter on SEC Form D filings · NJ, TX · Feb 15, 2011 → Aug 22, 2025

3deals (issuers)
$21.6Mreported sold
112investors
25Form D filings
2011–2025years on file
Follow this personLook further ↓PDF

Data last updated Oct 23, 2026, 5:45 PM ET · Courts (RECAP) last checked: Oct 24, 2026, 2:19 AM ET · SEC enforcement last checked: covered by the index scan as of Oct 24, 2026, 2:50 AM ET

The short version

Patrick T. Mooney is listed as an executive officer and director on 25 SEC Form D filings by 3 issuers between Jul 2009 and Apr 2026: Echo Therapeutics, Inc. (Iselin, NJ — biotechnology — 2009–2011; $10M reported sold to 46 investors), Linnaeus Therapeutics, Inc. (Haddonfield, NJ — biotechnology — 2018–2026; $5.82M reported sold to 26 investors) and MetaStat, Inc. (Boston, MA — biotechnology — 2012–2014; $5.74M reported sold to 40 investors).

What this means A repeat sponsor — 3 separate companies raised money with this person listed as executive officer and director, over about 17 years. Across those companies the filings report $21.6M sold in total.

Listed alongside Michael D. Poisel (11 shared filings), Todd Thomson (9 shared filings), Chris Arendt (7 shared filings), Daniel H. Schneiderman (7 shared filings), David Siegel (7 shared filings) and 20 others.

What this means These are the other officers, directors or promoters the companies named on the same forms — the team around Patrick. Each name links to their own page.

Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 1 bankruptcy case matching the name listed in Key records below.

What this means 1 record came back. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.

We compared 25 public filings for Patrick T. Mooney and found 18 differences, 3 worth asking the sponsor about: Amount sold went down between filings; Paid seller listed without a CRD number: Monarch Capital Group, LLC; and more below.

What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.

What the community is saying

Community search for Patrick T. Mooney has not run yet — it is joining a line of 9,370 names; searches run around the clock at the hosts' allowed rate. Searched so far: 27 names.

Community comments are quoted as written by their authors. Sources searched: BiggerPockets forums (via DuckDuckGo, Brave, Bing and BiggerPockets search) and Reddit (search feed + public archive).

Key records

Five things investors ask first. Items still in human review are counted, not shown.

1. Lawsuits

None found in sources searched — federal courts (CourtListener / RECAP), checked Oct 24, 2026

What was searched

Sources searched: CourtListener bulk data (RECAP dockets as of 2026-09-30; recall-first rule 10-24) — federal district + bankruptcy courts State courts: not covered (one-tap state court links under Look further). PACER: not searched. · Last checked Oct 24, 2026, 2:19 AM ET.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

2. Regulatory actions

None found in sources searched — SEC enforcement releases (index scan as of Oct 24, 2026, 2:50 AM ET) · state securities regulators: AZ, CA, DE, TX, WA (crawled Oct 23, 2026)

What was searched

SEC enforcement searched: SEC litigation releases and administrative proceedings — respondent names in the sec.gov index titles (30,205 releases, 1995-09-19 to 2026-10-23); release text is read only to confirm a candidate. Names that appear only in the body of a release are not found. — Searched SEC litigation releases and administrative proceedings (1995→ / 2007→) (30,205 records as of Oct 24, 2026, 2:50 AM ET) — nothing matched Patrick T. Mooney..

State securities regulators searched: AZ (Corporation Commission Securities Division), CA (DFPI — 16 of 12,159 DFPI respondent pages read so far; sponsor-name matches are read first), DE (DOJ Investor Protection Unit), TX (State Securities Board), WA (DFI) — last crawled Oct 23, 2026, 9:57 PM ET. Other states are not covered.

3. Bankruptcies

1 case: 1 closed (disposition not in docket feed)

Patrick Mooney closed
United States Bankruptcy Court, D. New Jersey · No. 09-16932 · Filed Mar 23, 2009 · Closed Sep 23, 2009
Role of Patrick Mooney: Debtor · Outcome: Case closed 2009-09-23 (disposition not included in the bulk docket feed — see docket) Docket on CourtListener ↗
same full name (a name found in 44 federal dockets); 3 people with this name in Form D filings; court in the person's filing state (NJ)
What was searched

Sources searched: Federal bankruptcy courts via CourtListener / RECAP archive (federal district courts, federal bankruptcy courts). State courts: not covered (one-tap state court links under Look further). PACER: not searched (RECAP only). · Last checked Oct 24, 2026, 2:19 AM ET.

Court records show docket facts only; we never restate allegations as facts. Outcome wording comes from the docket feed; where it does not state a disposition we say so.

State courts: not covered (one-tap state court links under Look further). No state offers a lawful automated statewide source PartnerFacts can use today. Texas (re:SearchTX) terms prohibit storing results in a database open to third parties; New York (WebCivil) and Massachusetts (MassCourts) require a browser check that blocks scripted queries; California has no statewide index (58 county portals; Rule of Court 2.503 grants name-based access case by case); Florida, Utah and Illinois offer paid or partial access whose terms for automated use are unverified. Washington (dw.courts.wa.gov; bulk index reports under a JISC data-dissemination agreement), Delaware (CourtConnect; Court of Chancery not included) and Arizona (apps.azcourts.gov/publicaccess, which has an official channel to request high-volume access) are the candidates; PartnerFacts will request written permission before any automated search. Federal courts are searched through CourtListener / RECAP.

4. Differences between public sources

Comparisons cover issuers and sponsor groups — see the issuer pages under Deals

18 differences found between the filings for Patrick T. Mooney — 3 worth asking about (compared 25 filings on Oct 24, 2026)

Worth asking · Nov 20, 2009 – Dec 7, 2009

Amount sold went down between filings — Echo Therapeutics, Inc.

The Nov 20, 2009 filing says $3,011,320 sold; the Dec 7, 2009 Form D says $562,500 sold — $2,448,820 less.

What this means Amounts sold normally only go up as a raise continues. A drop can mean investors were refunded, a figure was corrected, or an earlier number was wrong. Ask the sponsor which it was.

Form D (earlier) · Nov 20, 2009 ↗Form D (later) · Dec 7, 2009 ↗Echo Therapeutics, Inc. — PartnerFacts page ↗
Sources
Worth asking · Feb 15, 2011

Paid seller listed without a CRD number: Monarch Capital Group, LLC — Echo Therapeutics, Inc.

Monarch Capital Group, LLC is listed as receiving sales compensation on 1 filing (Feb 15, 2011) with no FINRA CRD number given.

What this means People paid to sell securities normally hold a FINRA registration with a CRD number. Without one we cannot look them up on BrokerCheck. Ask who they are and whether they are registered.

Form D/A · Feb 15, 2011 ↗BrokerCheck search: Monarch Capital Group, LLC ↗Echo Therapeutics, Inc. — PartnerFacts page ↗
Sources
Worth asking · Jul 7, 2009 – Feb 8, 2019

6 Form Ds were filed more than 15 days after the first sale

Form D filed 348 days after the first sale — MetaStat, Inc. · Form D filed 254 days after the first sale — Echo Therapeutics, Inc. · Form D filed 16 days after the first sale — Linnaeus Therapeutics, Inc. · Form D filed 29 days after the first sale — MetaStat, Inc. · Form D filed 39 days after the first sale — MetaStat, Inc. · and 1 more

What this means Late notices are common and carry no penalty by themselves. A pattern of late paperwork is worth asking the sponsor about.

Form D · Dec 24, 2013 ↗MetaStat, Inc. — PartnerFacts page ↗Form D · Oct 21, 2010 ↗Echo Therapeutics, Inc. — PartnerFacts page ↗
Sources
Note · Dec 26, 2024 – Aug 22, 2025

Patrick T. Mooney's role changed at Linnaeus Therapeutics, Inc.: executive officer → executive officer, director

The Dec 26, 2024 filing lists Patrick T. Mooney as executive officer; the Aug 22, 2025 Form D lists executive officer, director.

What this means Roles on Form D are self-reported by the issuer. A change can mean a real change in who runs the company, or just a different box ticked. Ask who makes decisions today.

Form D/A · Dec 26, 2024 ↗Form D · Aug 22, 2025 ↗Patrick T. Mooney — PartnerFacts page ↗Linnaeus Therapeutics, Inc. — PartnerFacts page ↗
Sources
Note · Jan 26, 2023 – Aug 12, 2024

Patrick T. Mooney's role changed at Linnaeus Therapeutics, Inc.: executive officer, director → executive officer

The Jan 26, 2023 filing lists Patrick T. Mooney as executive officer, director; the Aug 12, 2024 Form D lists executive officer.

What this means Roles on Form D are self-reported by the issuer. A change can mean a real change in who runs the company, or just a different box ticked. Ask who makes decisions today.

Form D · Jan 26, 2023 ↗Form D · Aug 12, 2024 ↗Patrick T. Mooney — PartnerFacts page ↗Linnaeus Therapeutics, Inc. — PartnerFacts page ↗
Sources
Note · Aug 12, 2024 – Dec 26, 2024

Offering amount changed between filings — Linnaeus Therapeutics, Inc.

The Aug 12, 2024 filing says $3,920,000 offered; the Dec 26, 2024 Form D/A says $6,860,000.

What this means The target raise changed. Raising the cap is common when a deal grows; ask whether the extra money has the same terms and use.

Form D (earlier) · Aug 12, 2024 ↗Form D/A (later) · Dec 26, 2024 ↗Linnaeus Therapeutics, Inc. — PartnerFacts page ↗
Sources
Note · Nov 20, 2009 – Dec 7, 2009

Offering amount lowered between filings — Echo Therapeutics, Inc.

The Nov 20, 2009 filing says $3,600,000 offered; the Dec 7, 2009 Form D says $562,500.

What this means The target raise got smaller. That can mean the plan shrank or the sponsor stopped early. Ask what changed in the deal.

Form D (earlier) · Nov 20, 2009 ↗Form D (later) · Dec 7, 2009 ↗Echo Therapeutics, Inc. — PartnerFacts page ↗
Sources
Note · Jul 28, 2009 – Nov 20, 2009

Offering amount changed between filings — Echo Therapeutics, Inc.

The Jul 28, 2009 filing says $2,006,031 offered; the Nov 20, 2009 Form D says $3,600,000.

What this means The target raise changed. Raising the cap is common when a deal grows; ask whether the extra money has the same terms and use.

Form D (earlier) · Jul 28, 2009 ↗Form D (later) · Nov 20, 2009 ↗Echo Therapeutics, Inc. — PartnerFacts page ↗
Sources
Note · Feb 9, 2010 – Aug 22, 2025

11 offerings have no amendment in the last 12 months and may still be open

No amendment in the last 12 months on an offering that may still be open — Linnaeus Therapeutics, Inc. (latest filing Aug 22, 2025) · No amendment in the last 12 months on an offering that may still be open — Linnaeus Therapeutics, Inc. (latest filing Dec 26, 2024) · No amendment in the last 12 months on an offering that may still be open — Linnaeus Therapeutics, Inc. (latest filing Feb 8, 2019) · No amendment in the last 12 months on an offering that may still be open — Linnaeus Therapeutics, Inc. (latest filing Sep 7, 2018) · No amendment in the last 12 months on an offering that may still be open — MetaStat, Inc. (latest filing Jul 8, 2014) · and 6 more

What this means SEC rules expect a yearly amendment while an offering is still going. Ask the sponsor which of these raises have closed.

Form D · Aug 22, 2025 ↗Linnaeus Therapeutics, Inc. — PartnerFacts page ↗Form D/A · Dec 26, 2024 ↗Form D · Feb 8, 2019 ↗
Sources
Note · Jul 28, 2009 – Feb 15, 2011

Patrick T. Mooney is written 2 different ways on the filings

listed as "Patrick Mooney" on 12 filings (from Jul 28, 2009), and "Patrick T. Mooney" on 13 filings (from Feb 15, 2011).

What this means Same person, written differently — a middle name or suffix left off, or spelled another way. It is normal, but check that the full legal name matches your subscription documents.

Form D · Jul 28, 2009 ↗Form D · Feb 15, 2011 ↗Patrick T. Mooney — PartnerFacts page ↗
Sources
Note · Jul 11, 2023 – Jun 5, 2025

Same name, different state: "Patrick Mooney" (CA) is a separate record

This page covers filings where the address state is NJ or TX. A separate record, "Patrick Mooney" with address state CA, is listed on 2 filings — most recently by SpyGlassPharma, Inc. (Jun 5, 2025). Both records have filings in the same period (Jul 11, 2023 to Jun 5, 2025).

What this means Two records with one name were active at the same time. That can be one person listing different company addresses, or two different people. We keep them apart until a filing ties them together. Check both pages before you decide.

Patrick Mooney (CA) — PartnerFacts page ↗Form D · Jun 5, 2025 ↗SpyGlassPharma, Inc. — PartnerFacts page ↗Patrick T. Mooney (NJ,TX) — this page ↗
Sources
Note · May 11, 2012 – Dec 24, 2013

Address moved from The Woodlands, TX to Montclair, NJ — MetaStat, Inc.

The people listed on the May 11, 2012 filing give The Woodlands, TX; on the Dec 24, 2013 filing they give Montclair, NJ.

What this means Businesses move; this just shows the two places and dates. If you were told one city and the forms say another, ask which is current.

Form D · May 11, 2012 ↗Form D · Dec 24, 2013 ↗MetaStat, Inc. — PartnerFacts page ↗
Sources
Note · Jul 28, 2009 – Apr 2, 2026

Patrick T. Mooney is listed with 2 different address states: NJ, TX

NJ on 24 filings (Jul 28, 2009 to Apr 2, 2026); TX on 1 filing (May 11, 2012).

What this means The address on a Form D is usually the company's, not the person's home, so this often just reflects different companies. It can also mean a move. Nothing wrong by itself.

Form D · Jul 28, 2009 ↗Form D · May 11, 2012 ↗
Sources
Note · May 11, 2012 – Jun 20, 2014

Reported revenue range changed between filings — MetaStat, Inc.

"Decline to Disclose" (May 11, 2012); then "No Revenues" (Jan 24, 2014); then "Decline to Disclose" (Jun 20, 2014).

What this means This is the size band the issuer picks for itself on the form. A change can mean the business grew or shrank — or that it chose not to say. Ask for current numbers.

Form D · May 11, 2012 ↗Form D · Jan 24, 2014 ↗Form D · Jun 20, 2014 ↗MetaStat, Inc. — PartnerFacts page ↗
Sources
Note · Jul 28, 2009 – Oct 21, 2010

Reported revenue range changed between filings — Echo Therapeutics, Inc.

"$1,000,001 - $5,000,000" (Jul 28, 2009); then "$1 - $1,000,000" (Oct 21, 2010).

What this means This is the size band the issuer picks for itself on the form. A change can mean the business grew or shrank — or that it chose not to say. Ask for current numbers.

Form D · Jul 28, 2009 ↗Form D · Oct 21, 2010 ↗Echo Therapeutics, Inc. — PartnerFacts page ↗
Sources
Note · Nov 5, 2010 – Feb 15, 2011

Minimum investment changed between filings — Echo Therapeutics, Inc.

The Nov 5, 2010 filing lists a minimum of $25,000; the Feb 15, 2011 Form D/A lists $10,000.

What this means A different minimum usually means the offering terms changed. Check which terms apply to you.

Form D (earlier) · Nov 5, 2010 ↗Form D/A (later) · Feb 15, 2011 ↗Echo Therapeutics, Inc. — PartnerFacts page ↗
Sources
Note · Nov 20, 2009 – Dec 7, 2009

Minimum investment changed between filings — Echo Therapeutics, Inc.

The Nov 20, 2009 filing lists a minimum of $56,250; the Dec 7, 2009 Form D lists $12,500.

What this means A different minimum usually means the offering terms changed. Check which terms apply to you.

Form D (earlier) · Nov 20, 2009 ↗Form D (later) · Dec 7, 2009 ↗Echo Therapeutics, Inc. — PartnerFacts page ↗
Sources
Note · Jul 28, 2009 – Nov 20, 2009

Minimum investment changed between filings — Echo Therapeutics, Inc.

The Jul 28, 2009 filing lists a minimum of $2,000,000; the Nov 20, 2009 Form D lists $56,250.

What this means A different minimum usually means the offering terms changed. Check which terms apply to you.

Form D (earlier) · Jul 28, 2009 ↗Form D (later) · Nov 20, 2009 ↗Echo Therapeutics, Inc. — PartnerFacts page ↗
Sources
What is compared

What is compared: every Form D and D/A we hold for this subject, side by side — filing dates vs. first-sale dates (the 15-day rule), amendment timing on open offerings (the yearly-amendment expectation), amounts sold, investor counts, offering amounts and minimums across amendments, industry and size bands, addresses, how each person's name and role is written, paid sellers' CRD numbers, and (for groups) where the member companies were formed and sit. Everything is as filed by the issuer; the SEC does not check it. Differences are common and usually have ordinary explanations — we show both values, the dates, and the source so you can ask. As of Oct 24, 2026.

5. Money to insiders

6 of 18 offerings report sales commissions totalling $1,315,295; 0 report finder's fees; 2 report proceeds to related persons totalling $128,919. (includes amounts the issuer reported as estimates)

Offering (latest filing)Sales commissionsFinder's feesTo insidersPaid to sell itSource
Apr 2, 2026 D/A
Linnaeus Therapeutics, Inc.
File 021-574940
$0$0$0None listed on this filingEDGAR ↗
Aug 22, 2025 D
Linnaeus Therapeutics, Inc.
File 021-555635
$0$0$0None listed on this filingEDGAR ↗
Dec 26, 2024 D/A
Linnaeus Therapeutics, Inc.
File 021-521284
$0$0$0None listed on this filingEDGAR ↗
Jan 26, 2023 D
Linnaeus Therapeutics, Inc.
File 021-471863
$0$0$0None listed on this filingEDGAR ↗
Aug 24, 2021 D
Linnaeus Therapeutics, Inc.
File 021-411057
$0$0$0None listed on this filingEDGAR ↗
Feb 8, 2019 D
Linnaeus Therapeutics, Inc.
File 021-332423
$0$0$28,919 (est.)
Approximately $28,919 of the proceeds may be used to repay the remaining principal of a promissory note made to the issuer by the issuer's CEO. The decision to repay the principal will be at the discretion of the issuer's board of directors.
None listed on this filingEDGAR ↗
Sep 7, 2018 D
Linnaeus Therapeutics, Inc.
File 021-320902
$0$0$100,000 (est.)
Approximately $100,000 of the proceeds of this offering may be used to repay the principal of a promissory note made to the issuer by the issuer's CEO. The decision to repay the principal will be at the discretion of the issuer's board of directors.
None listed on this filingEDGAR ↗
Jul 8, 2014 D
MetaStat, Inc.
File 021-220581
$0 (est.)$0 (est.)$0 (est.)None listed on this filingEDGAR ↗
Jun 20, 2014 D
MetaStat, Inc.
File 021-219613
$0$0$0None listed on this filingEDGAR ↗
Mar 26, 2014 D
MetaStat, Inc.
File 021-214284
$1,000,000 (est.)$0$0John Carris Investments BrokerCheck CRD 145767 ↗
via John Carris Investments (CRD 145767 ↗)
EDGAR ↗
Jan 24, 2014 D
MetaStat, Inc.
File 021-210644
$48,000$0$0Axiom Capital Management, Inc. BrokerCheck CRD 26580 ↗EDGAR ↗
Dec 24, 2013 D
MetaStat, Inc.
File 021-208704
$16,960$0$0Noble Financial Capital Markets BrokerCheck CRD 15768 ↗
via Rockwell Global Capital, LLC (CRD 142485 ↗)
EDGAR ↗
Dec 24, 2013 D
MetaStat, Inc.
File 021-208705
$0$0$0None listed on this filingEDGAR ↗
May 11, 2012 D
MetaStat, Inc.
File 021-178111
$0$0$0None listed on this filingEDGAR ↗
Feb 15, 2011 D/A
Echo Therapeutics, Inc.
File 021-150069
$65,625$0$0LifeTech Capital, a division of Aurora Capital, LLC BrokerCheck CRD 37924 ↗
Monarch Capital Group, LLC no CRD number reported		EDGAR ↗
Feb 15, 2011 D
Echo Therapeutics, Inc.
File 021-155409
$0$0$0None listed on this filingEDGAR ↗
Oct 21, 2010 D
Echo Therapeutics, Inc.
File 021-149437
$140,335$0$0BOENNING & SCATTERGOOD, INC. BrokerCheck CRD 100 ↗
BURNHAM HILL PARTNERS LLC BrokerCheck CRD 148000 ↗		EDGAR ↗
Dec 7, 2009 D
Echo Therapeutics, Inc.
File 021-59012
$44,375$0$0BOENNING & SCATTERGOOD, INC. BrokerCheck CRD 100 ↗EDGAR ↗
How this is counted

Counts come from Form D Items 12–15 on the filings in our index (latest filing per offering; one offering = one SEC file number; an amendment updates its offering rather than adding one). "To insiders" = gross proceeds used for payments to executive officers, directors or promoters. "—" = not reported on that filing. Amounts marked (est.) were reported as estimates. "Paid to sell it" = sales compensation recipients named on that filing (Item 12), each linked to FINRA BrokerCheck when a CRD number is reported.

Counted across every filing this person is listed on (latest filing per offering, per issuer).

Deals 3

Every issuer that named Patrick T. Mooney on a Form D, newest first. A Form D is the notice a company files after it starts selling a private investment.

LT
Biotechnology

Linnaeus Therapeutics, Inc.

Haddonfield, NJ · Sep 7, 2018 → Apr 2, 2026 · 11 filings
  • Apr 2, 2026 · D/A · $4,992,000 sold of $10,000,000 · 26 investors · min. $1 · role: Executive Officer, Director EDGAR ↗
  • Mar 31, 2026 · D/A · $4,892,000 sold of $10,000,000 · 26 investors · min. $1 · role: Executive Officer, Director EDGAR ↗
  • Mar 13, 2026 · D/A · $4,792,000 sold of $10,000,000 · 25 investors · min. $1 · role: Executive Officer, Director EDGAR ↗
  • Feb 27, 2026 · D · $4,475,000 sold of $10,000,000 · 19 investors · min. $1 · role: Executive Officer, Director EDGAR ↗
  • Aug 22, 2025 · D · $1,275,000 sold of $10,000,000 · 3 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • Dec 26, 2024 · D/A · $5,824,155 sold of $6,860,000 · 12 investors · min. No minimum reported · role: Executive Officer EDGAR ↗
  • Aug 12, 2024 · D · $1,628,398 sold of $3,920,000 · 6 investors · min. No minimum reported · role: Executive Officer EDGAR ↗
  • Jan 26, 2023 · D · $3,088,234 sold of $3,088,234 · 8 investors · min. $15,700 · role: Executive Officer, Director EDGAR ↗
  • Aug 24, 2021 · D · $4,344,675 sold of $4,344,675 · 15 investors · min. $24,999 · role: Executive Officer, Director EDGAR ↗
  • Feb 8, 2019 · D · $2,160,000 sold of Indefinite · 3 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • Sep 7, 2018 · D · $2,160,000 sold of Indefinite · 4 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗

Raised $5.82M from 26 investors (58% of the $10M target) as of the latest filing. Patrick is listed as executive officer, director on 11 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

M
Biotechnology

MetaStat, Inc.

Boston, MA · May 11, 2012 → Jul 8, 2014 · 7 filings
  • Jul 8, 2014 · D · $5,735,427 sold of $10,000,000 · 40 investors · min. No minimum reported · role: Director EDGAR ↗
  • Jun 20, 2014 · D · $215,000 sold of $600,000 · 6 investors · min. No minimum reported · role: Director EDGAR ↗
  • Mar 26, 2014 · D · $0 sold of $10,000,000 · 0 investors · min. $25,000 · role: Director EDGAR ↗
  • Jan 24, 2014 · D · $650,000 sold of $1,000,000 · 5 investors · min. No minimum reported · role: Director EDGAR ↗
  • Dec 24, 2013 · D · $500,000 sold of $500,000 · 3 investors · min. No minimum reported · role: Director EDGAR ↗
  • Dec 24, 2013 · D · $1,487,000 sold of $1,500,000 · 22 investors · min. No minimum reported · role: Director EDGAR ↗
  • May 11, 2012 · D · $880,000 sold of $2,000,000 · 13 investors · min. No minimum reported · role: Director EDGAR ↗

Raised $5.74M from 40 investors (57% of the $10M target) as of the latest filing. Patrick is listed as director on 7 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer. "Similar" = offerings in the same industry claiming the same exemption, filed in the last 5 years: Biotechnology / 506(b) (3,253 filings); ranges are the middle half (25th–75th percentile). Computed by PartnerFacts from SEC EDGAR Form D data as of Oct 23, 2026, 5:45 PM ET. Rows without a range: fewer than 30 comparable filings, or not a Rule 506 offering. No ranking or score.

ET
Other Health Care

Echo Therapeutics, Inc.

Iselin, NJ · Jul 28, 2009 → Feb 15, 2011 · 7 filings
  • Feb 15, 2011 · D · $3,506,000 sold of $3,506,000 · 3 investors · min. $500,000 · role: Executive Officer, Director EDGAR ↗
  • Feb 15, 2011 · D/A · $2,896,500 sold of $3,000,000 · 46 investors · min. $10,000 · role: Executive Officer, Director EDGAR ↗
  • Nov 5, 2010 · D · $0 sold of $3,000,000 · 0 investors · min. $25,000 · role: Executive Officer, Director EDGAR ↗
  • Oct 21, 2010 · D · $2,455,126 sold of $5,000,000 · 38 investors · min. No minimum reported · role: Executive Officer, Director EDGAR ↗
  • Dec 7, 2009 · D · $562,500 sold of $562,500 · 9 investors · min. $12,500 · role: Executive Officer, Director EDGAR ↗
  • Nov 20, 2009 · D · $3,011,320 sold of $3,600,000 · 8 investors · min. $56,250 · role: Executive Officer, Director EDGAR ↗
  • Jul 28, 2009 · D · $2,006,031 sold of $2,006,031 · 1 investors · min. $2,000,000 · role: Executive Officer, Director EDGAR ↗

Raised $10M from 46 investors (100% of the $3.51M target) as of the latest filing. Patrick is listed as executive officer, director on 7 filings for this deal.

Latest filing on EDGAR ↗
Sources

Every row is a Form D or D/A on which the issuer listed this name as a related person. Amount sold and investors are the maximum reported on any filing for this issuer.

Other pages with the same name (2)

Separate person records under the same name, not combined with this page. Each line says whether it shares an issuer with this record.

  • Patrick R. Mooney — British Columbia, Canada (as filed: A1), 1 issuer, Jul 1, 2013 → Jul 1, 2013 · no shared issuer
  • Patrick Mooney — CA, 1 issuer, Jul 11, 2023 → Jun 5, 2025 · no shared issuer

People around Patrick 25

Officers, directors, promoters and management entities named on the same filings, as of Oct 23, 2026, 5:45 PM ET.

MP
No photo found yet (own website and image search run after this page is viewed)
Person

Michael D. Poisel

Director · 11 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Patrick T. Mooney. Their page shows their other deals.

TT
No photo found yet (own website and image search run after this page is viewed)
Person

Todd Thomson

Director · 9 shared filings (1 issuer)

Listed on the same filings as Patrick T. Mooney. Their page shows their other deals.

SS
No photo found yet (own website and image search run after this page is viewed)
Person

Shawn K. Singh

Director · 7 shared filings (1 issuer) · also on 3 other issuers

Listed on the same filings as Patrick T. Mooney. Their page shows their other deals.

HM
No photo found yet (own website and image search run after this page is viewed)
Person

HARRY MITCHELL

Executive Officer · 7 shared filings (1 issuer)

Listed on the same filings as Patrick T. Mooney. Their page shows their other deals.

VE
No photo found yet (own website and image search run after this page is viewed)
Person

VINCENT ENRIGHT

Director · 7 shared filings (1 issuer)

Listed on the same filings as Patrick T. Mooney. Their page shows their other deals.

DS
No photo found yet (own website and image search run after this page is viewed)
Person

Daniel H. Schneiderman

Executive Officer · 7 shared filings (1 issuer)

Listed on the same filings as Patrick T. Mooney. Their page shows their other deals.

JD
No photo found yet (own website and image search run after this page is viewed)
Person

James Demetriades

Director · 7 shared filings (1 issuer)

Listed on the same filings as Patrick T. Mooney. Their page shows their other deals.

CA
No photo found yet (own website and image search run after this page is viewed)
Person

Chris Arendt

Director · 7 shared filings (1 issuer)

Listed on the same filings as Patrick T. Mooney. Their page shows their other deals.

DS
No photo found yet (own website and image search run after this page is viewed)
Person

David Siegel

Director · 7 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Patrick T. Mooney. Their page shows their other deals.

WL
No photo found yet (own website and image search run after this page is viewed)
Person

Warren C. Lau

Executive Officer, Director · 6 shared filings (1 issuer)

Listed on the same filings as Patrick T. Mooney. Their page shows their other deals.

DE
No photo found yet (own website and image search run after this page is viewed)
Person

David Epstein

Director · 6 shared filings (1 issuer) · also on 2 other issuers

Listed on the same filings as Patrick T. Mooney. Their page shows their other deals.

WW
No photo found yet (own website and image search run after this page is viewed)
Person

WALTER WITOSHKIN

Director · 5 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Patrick T. Mooney. Their page shows their other deals.

JS
No photo found yet (own website and image search run after this page is viewed)
Person

Johan (Thijs) M. Spoor

Director · 5 shared filings (1 issuer) · also on 1 other issuer

Listed on the same filings as Patrick T. Mooney. Their page shows their other deals.

NI
No photo found yet (own website and image search run after this page is viewed)
Person

Nicholas Iatropoulos

Director · 4 shared filings (1 issuer)

Listed on the same filings as Patrick T. Mooney. Their page shows their other deals.

JL
No photo found yet (own website and image search run after this page is viewed)
Person

John Lepping

Director · 4 shared filings (1 issuer)

Listed on the same filings as Patrick T. Mooney. Their page shows their other deals.

RL
No photo found yet (own website and image search run after this page is viewed)
Person

Robert Langer

Director · 3 shared filings (1 issuer) · also on 47 other issuers

Robert Langer is on 48 issuers in total — a repeat sponsor. Their page lists every one.

OB
No photo found yet (own website and image search run after this page is viewed)
Person

Oscar L. Bronsther

Executive Officer, Director · 3 shared filings (1 issuer)

Listed on the same filings as Patrick T. Mooney. Their page shows their other deals.

OB
No photo found yet (own website and image search run after this page is viewed)
Person

Oscar Bronsther

Executive Officer, Director · 3 shared filings (1 issuer)

Listed on the same filings as Patrick T. Mooney. Their page shows their other deals.

WG
No photo found yet (own website and image search run after this page is viewed)
Person

WILLIAM F. GRIECO

Director · 2 shared filings (1 issuer)

Listed on the same filings as Patrick T. Mooney. Their page shows their other deals.

CN
No photo found yet (own website and image search run after this page is viewed)
Person

Christopher Natale

Executive Officer · 2 shared filings (1 issuer)

Listed on the same filings as Patrick T. Mooney. Their page shows their other deals.

JS
No photo found yet (own website and image search run after this page is viewed)
Person

James Smith

Director · 2 shared filings (1 issuer) · also on 3 other issuers

Listed on the same filings as Patrick T. Mooney. Their page shows their other deals.

KB
No photo found yet (own website and image search run after this page is viewed)
Person

KIMBERLY BURKE

Executive Officer · 1 shared filing (1 issuer)

Listed on the same filings as Patrick T. Mooney. Their page shows their other deals.

JL
No photo found yet (own website and image search run after this page is viewed)
Person

Jack Lepping

Director · 1 shared filing (1 issuer)

Listed on the same filings as Patrick T. Mooney. Their page shows their other deals.

JS
No photo found yet (own website and image search run after this page is viewed)
Person

Johan M. Spoor

Director · 1 shared filing (1 issuer)

Listed on the same filings as Patrick T. Mooney. Their page shows their other deals.

OB
No photo found yet (own website and image search run after this page is viewed)
Person

Oscar M. Bronsther

Executive Officer, Director · 1 shared filing (1 issuer)

Listed on the same filings as Patrick T. Mooney. Their page shows their other deals.

The team behind the deals

Same business address

1 other issuer file from the same address

A shared address can mean the same team, a shared office building or a registered agent. It is a lead, not a conclusion.

Registrations and other filings

Adviser registration (Form ADV)

None of the 3 issuers this person is listed on appears in Form ADV (searched 24,962 advisers as of Oct 2, 2026). A person is never an adviser firm; Form ADV is checked for the issuers and the management companies they are listed with.

Other offering types (Regulation A and Regulation Crowdfunding)

Searched SEC Regulation A Data Sets (Forms 1-A, 1-K, 1-Z; 2015 Q2 → 2026 Q3); SEC Crowdfunding Offerings Data Sets (Form C family; 2016 Q2 → 2026 Q3); EDGAR form index for 2026 Q3 → 2026 Q4 (51,358 records as of Oct 23, 2026, 8:41 PM ET) — nothing matched this name.

Property records none — individuals are not matched

Property records are matched to companies only, never to individuals, so none are matched to Patrick T. Mooney by design. Searched property records in Hillsborough County FL (Clerk recorded-document index Oct 14, 2026 to Oct 15, 2026 + FL DOR 2026 ownership roll), Miami-Dade County FL (FL DOR 2026 ownership roll), Harris County TX (HCAD 2026 ownership roll), Dallas County TX (DCAD 2026 ownership roll), New York City ACRIS documents and PLUTO ownership rows already retrieved for other issuers, Cook County IL sale and ownership rows already retrieved for other issuers (814,874 records as of Oct 23, 2026, 8:59 PM ET) for the 3 issuers this person is listed on — nothing matched.

Public profiles and social

Websites and social links of the issuers Patrick T. Mooney is listed on: none on file. No website or social profile named in Linnaeus Therapeutics, Inc.'s SEC filings (Form C, Reg A, Form ADV; checked Oct 24, 2026). Web search for this name: #34,444 of 374,652 in line (14 issuers searched so far). One-tap searches: Look further ↓

Look further

One-tap searches on sites we do not index ourselves, with the name pre-filled (Haddonfield, NJ). Each opens in a new tab; what you find there is not verified by PartnerFacts.

Social and web

LinkedIn people search ↗Instagram ↗X (Twitter) ↗Facebook ↗YouTube ↗Google ↗Google Images ↗Google News ↗Meta Ad Library ↗

Courts

CourtListener / RECAP (federal) ↗PACER case locator (federal, login) ↗New Jersey state courts — find the court ↗Texas re:SearchTX court records ↗Massachusetts MassCourts ↗

Securities regulators

SEC EDGAR full-text search ↗SEC action look-up ↗FINRA BrokerCheck ↗SEC IAPD adviser search ↗

Business registries

New Jersey Secretary of State business search ↗Texas Secretary of State business search ↗Massachusetts Secretary of State business search ↗OpenCorporates ↗

Change history

No corrections have been requested for this page.

Every fact links to its public-record source. Plain-English notes next to a fact are our reading of that fact, not a rating. Request a correction · Facts policy

Request a correction

Free. Logged with status: received → under review → fixed / confirmed with source.

Add a response

If this is you or your firm, add a sourced explanation next to any fact. Reviewed before publishing.

Monitor this person

Members get an email when Patrick T. Mooney appears on a new Form D, or when a court case or SEC action is matched to them. See plans →